Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
QG

NYSE · QGEN

Qiagen N.V.

Healthcare · Medical - Diagnostics & Research

$50.22

Down-$0.12 (-0.24%)

Updated Oct 31, 2026, 5:14 PM

SID Score

6.7/10

Composite research score

Smart Money

58/100

Neutral

Market cap
9.85B
P/E ratio
24.3
Dividend yield
3.01%
52-week range
$32.53 – $57.82
Volume
4.17M
Avg. volume
1.17M

Price performance · QGEN

QGEN price history

1M range · 0 trading sessions · Daily adjusted prices

QGEN does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest QGEN news

The latest Smart Investors Daily articles mentioning QGEN.

Stock researchCompany · Overview

QGEN research

Overview

Company profile and research snapshot.

Company profile

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$53.00
Implied upside
—
Analysts
—
QGEN recent ratings
DateFirmRatingTarget
Oct 28, 2026BarclaysEqual-Weight—
Oct 26, 2026CitigroupNeutral—
Oct 22, 2026JP MorganNeutral—
Oct 22, 2026BairdOutperform—
Oct 14, 2026JP MorganOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 24, 2026

Can EQT (OM:EQT) Still Be Undervalued Or Is Growth Priced In?

EQT AB has been busy expanding its private markets footprint, and the share price performance over the past few years means investors are asking a simple question. Is today’s EQT stock price supported by the returns the business earns on the capital it puts to work in these deals. Over the past 3 years EQT has delivered a total return of 56.5%, which puts real weight on whether its return on capital justifies that kind of share price outcome. The agreed takeovers of groups like Cleanaway,...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By